NCT06855277 Study Comparing AAA817+ARPI Versus Standard of Care in Adult Participants With PSMA-positive mCRPC Status RECRUITING Phase PHASE3
NCT06842264 The Development and Validation of MRI-AI-based Predictive Models for csPCa Status RECRUITING Phase N/A
NCT06841211 Optimizing Prostate Biopsy Schemes in Men With Multiple mpMRI Visible Lesions Status RECRUITING Phase NA
NCT06840535 A Study to Evaluate the Safety and Dosimetry of 68Ga-OncoACP3 in Patients With Prostate Cancer Status COMPLETED Phase PHASE1
NCT06837896 Efficacy and Safety Study of QLG1080 in Patients With Hormone-sensitive Advanced Prostate Cancer Status NOT_YET_RECRUITING Phase PHASE3
NCT06836648 Single Patient Compassionate Use of X-PACT in Salvage Treatment of Prostate Cancer Status AVAILABLE Phase N/A
NCT06828003 Feasibility of a Remotely-Delivered Resistance Training Program for Cognitive Function in Men Living With and Beyond Prostate Cancer Status NOT_YET_RECRUITING Phase NA
NCT06826768 A Ph Ib Study of REGN5678 Plus Cemiplimab in Patients With mCRPC Status RECRUITING Phase PHASE1
NCT06824818 Study to Assess the Feasibility of Stopping Prostate Cancer Treatment Early in Elderly Patients Status RECRUITING Phase NA
NCT06824259 The Value of Dual-parametric Magnetic Resonance Combined With Regional Saturation Biopsy in Patients With Suspected Prostate Cancer Status ACTIVE_NOT_RECRUITING Phase NA
NCT06815055 State of Play of Physiotherapy in the Postoperative Management of Prostate Cancer : Prospective, Monocentric, National Survey, Aiming to Explore the Technics of Physiotherapy (PREduKiné) Status NOT_YET_RECRUITING Phase N/A
NCT06807359 Photodynamic Therapy of Primary Localized Prostate Cancer With the SpectraCure P18 System Status RECRUITING Phase PHASE1/PHASE2
NCT06804785 Hybrid Intelligence for Trustable Diagnosis and Patient Management of Prostate Cancer (HIT-PIRADS) Status RECRUITING Phase N/A
NCT06795191 Efficacy, Safety, and Pharmacokinetics of FP-014, 22.5 mg in Patients With Advanced Prostate Cancer Status WITHDRAWN Phase PHASE3
NCT06795178 Efficacy, Safety, and Pharmacokinetics of FP-014, 11.25 mg in Patients With Advanced Prostate Cancer Status WITHDRAWN Phase PHASE3